Research on the establishment of surveillance medicine by exploratory analysis of viral specimens and investigation of subclinical infections

Research on the establishment of surveillance medicine by exploratory analysis of viral specimens and investigation of subclinical infections. (Prospective cross-sectional case series study) - Prospective cross-sectional case series study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053960

Enrollment

2500

Registered

2024-03-26

Start date

2024-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outpatients with fever and general outpatients

Interventions

Saliva taken

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients with fever and general outpatients

Exclusion criteria

Exclusion criteria: Those who cannot give their consent to participate

Design outcomes

Primary

Measure	Time frame
(1) Age, gender, smoking status, alcohol consumption, underlying disease, medications, physical examination (body temperature, blood pressure, pulse rate, respiratory rate, oxygen saturation (SpO2), etc.) (2) Blood tests: blood count, CRP, AST, ALT, LDH, ALP, total bilirubin, creatinine, etc. (3) Clinical information related to respiratory tract infection: route of infection, diagnostic method, date of onset, date of resolution of fever, symptoms, therapeutic drugs, type of respiratory care, number of vaccinations, adverse reaction information, or complications caused by respiratory tract infection, date of diagnosis, date of complete recovery, sequela, etc. (4) Drug prescriptions and treatment records	—

Measure

Time frame

(1) Age, gender, smoking status, alcohol consumption, underlying disease, medications, physical examination (body temperature, blood pressure, pulse rate, respiratory rate, oxygen saturation (SpO2), etc.) (2) Blood tests: blood count, CRP, AST, ALT, LDH, ALP, total bilirubin, creatinine, etc. (3) Clinical information related to respiratory tract infection: route of infection, diagnostic method, date of onset, date of resolution of fever, symptoms, therapeutic drugs, type of respiratory care, number of vaccinations, adverse reaction information, or complications caused by respiratory tract infection, date of diagnosis, date of complete recovery, sequela, etc. (4) Drug prescriptions and treatment records

—

Countries

Japan

Contacts

Public ContactEiryo Kawakami

Graduate School of Medicine Artificial Intelligence Medicine

ai-med@chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026